Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study

Autor: Mu-Jian Teng, Qiao-Nan Shan, Gang Chen, Tao Jiang, Nan Jiang, Da-Wei Zhou, Rui Wang, Lai-Bang Luo, Chang-Ku Jia, Yang Yang, Jin-Zhen Cai, Ren-Yi Su, Li Li, Ren Lang, Cai-De Lu, Shao-Jun Ye, Qiang He, Qifa Ye, Pusen Wang, Zhi-Ren Fu, Qiang Xia, Shao-Hua Song, Tao Lv, Kang He, Guoyue Lv, Li-Bo Sun, Wei Qiu, Ze-Min Hu, Zi-Qiang Li, Sheng-Dong Wu, Dong Chen, Jian-Hua Shi, Xiaoshun He, Quan-Bao Zhang, Zheng Wang, Jian Zhou, Min Tian, Ji-Zhou Wang, Lin-Sen Ye, Zhi-Hai Peng, Xuyong Wei, Wei Rao, Bo Wang, Rui-Peng Song, Sunbin Ling, Bin Xie, Yuting He, Qi-Gen Li, Wen-Zhi Guo, Lin Zhong, Jia-Yin Yang, Zhi-Dan Xu, Jing-Sheng Ma, Zhi-Yong Guo, Liu-Gen Lan, Tai-Shi Fang, Shusen Zheng, Xiao Xu, Qi-Jie Luo, Zhongzhou Si, Wen-tao Jiang, Zhao-Jie Su, Dong-Hua Zhang, Xu-Yong Sun, Kun Zhang, Li Zhuang, Ying-Peng Zhao, Zheng-Xin Wang, Xuan Wang, Jun-Jie Li, Jiang Liu, Guang-Ming Li, Ning-Qi Zhu, Zhishui Chen, Li-Min Ding, Tian Shen, Jian-Hua Li, Chang-Jiang Lu, Qian Lu

Publikováno v: Hepatobiliarypancreatic diseases international : HBPD INT. 21(2)

Mammalian target of rapamycin (mTOR) inhibitor as an attractive drug target with promising antitumor effects has been widely investigated. High quality clinical trial has been conducted in liver transplant (LT) recipients in Western countries. Howeve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::243fee2e1d58f5eb320ccea65a178c93
https://pubmed.ncbi.nlm.nih.gov/34583911